Stevens–Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn’s Disease
Joint Authors
Milani, Stefano
Tarocchi, Mirko
Mello, Tommaso
Roselli, Jenny
Innocenti, Tommaso
Lynch, Erica Nicola
Parisio, Laura
Apolito, Pasquale
Macrì, Giuseppe
Milla, Monica
Biagini, Maria Rosa
Galli, Andrea
Source
Case Reports in Gastrointestinal Medicine
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-04-15
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Stevens–Johnson syndrome (SJS) is a severe mucocutaneous adverse drug reaction with a relatively high mortality rate.
SJS is described during herpes simplex virus type 1 (HSV1) infection and, rarely, even during adalimumab therapy.
We report the case of a patient with Crohn’s disease who developed SJS during an HSV1 infection and a contemporaneous anti-TNFα therapy with adalimumab.
Remission was achieved with suspension of adalimumab and high doses of intravenous steroids and antivirals.
Patients with HSV1 infection and on adalimumab therapy have a combined risk of SJS and should be monitored closely.
American Psychological Association (APA)
Roselli, Jenny& Innocenti, Tommaso& Lynch, Erica Nicola& Parisio, Laura& Apolito, Pasquale& Mello, Tommaso…[et al.]. 2020. Stevens–Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn’s Disease. Case Reports in Gastrointestinal Medicine،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1147374
Modern Language Association (MLA)
Roselli, Jenny…[et al.]. Stevens–Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn’s Disease. Case Reports in Gastrointestinal Medicine No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1147374
American Medical Association (AMA)
Roselli, Jenny& Innocenti, Tommaso& Lynch, Erica Nicola& Parisio, Laura& Apolito, Pasquale& Mello, Tommaso…[et al.]. Stevens–Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn’s Disease. Case Reports in Gastrointestinal Medicine. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1147374
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1147374